CBD and Phytocannabinoids do not inhibit the production of endocannabinoids

CBD und Phytocannabinoide hemmen die Produktion von Endocannabinoiden nicht Von Prof. Gene Bruno, MS, MHS, RH(AHG) Huntington College für Gesundheitswissenschaften In letzter Zeit habe ich viel Zeit damit verbracht, die Forschung zur Wirkung von CBD und Phytocannabinoiden auf das Endocannabinoid-System zu studieren. Als ich diese Forschung mit Kollegen diskutierte, war ich daran interessiert zu erfahren, dass einige Leute besorgt waren, dass eine Supplementierung mit CBD/Phytocannabinoiden die körpereigene Produktion von Endocannabinoiden beeinträchtigen könnte – ähnlich wie Testosteron-Injektionen dazu führen, dass der Körper weniger davon produziert eigenes Testosteron. Ich freue mich, Ihnen mitteilen zu können, dass diese Sorge unbegründet ist. Im Gegensatz …
CBD and Phytocannabinoids do not inhibit the production of endocannabinoids from Prof. Gene Bruno, MS, MHS, RH (AHG) Huntington College for Health Sciences Lately I have spent a lot of time to study research on the effect of CBD and Phytocannabinoids on the endocannabinoid system. When I discussed this research with colleagues, I was interested to find out that some people were concerned that supplementing with CBD/Phytocannabinoids could impair the body's own production of endocannabinoids-similar to testosterone injections, the body produces less of it. I am pleased to be able to tell you that this concern is unfounded. In contrast ... (Symbolbild/natur.wiki)

CBD and Phytocannabinoids do not inhibit the production of endocannabinoids

CBD and Phytocannabinoids do not inhibit the production of endocannabinoids

by Prof. Gene Bruno, MS, MHS, RH (AHG)

Huntington College for Health Sciences

Lately I have spent a lot of time to study research on the effect of CBD and Phytocannabinoids on the Endocannabinoid system. When I discussed this research with colleagues, I was interested to find out that some people were concerned that supplementation with CBD/Phytocannabinoids could impair the body's own production of endocannabinoids-similar to testosterone injections, the body is less producing its own testosterone .

I am happy to be able to tell you that this concern is unfounded. In contrast to testosterone in injections, which essentially has the same chemical structure as the body's testosterone, phytocannabinoids do not have the same chemical structure as the endocannabinoids produced in the body. It works in this way.

n-arachidonyllethanolamide (AEA) and SN-2-Arachidonoylglycerol (2-AG) are the two endocannabinoids produced in the body that bind to receptors within the endocannabinoid system (ECS). After that, an enzyme in the body called fatty acid hydrolase (FAAH) AEA and 2-AG-which means that there are now less endocannabinoids to perform their task. In combination with other factors (e.g. inadequate consumption of phytocannabinoids containing food such as broccoli, cabbage, carrots, parsley, 1 sunflower seeds and peas), this can lead to a suboptimal function of the ECB system, also known as "ECB deficiency syndrome". The condition can be associated with migraines, fibromyalgia, irritable bowel syndrome, mental disorders and other diseases. 3

However, if significant amounts of phytocannabinoids such as CBD are consumed, the FAAH is used to dismantle it instead of reducing the endocannabinoids. This helps to maintain a healthy endocannabinoid level and to extend their effect. 4

This series of Phytocannabinoids has a value as an entourage connections to increase the effect of endocannabinoids by inhibiting their hydrolysis through substrate competition and extending their effect. The use of phytocannabinoids clearly does not mean that the body produces less of its own endocannabinoids - on the contrary.

references:

1. Gertsch J, Pertwee RG, Di Marzo V. Phytocannabinoids beyond the cannabis plant - is they? br. J. Pharmacol. June 2010; 160 (3): 523-9.

  • Hanuš Lo, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoid: A uniform critical inventory. Nat. Prod. Rep. 2016 Nov 23; 33 (12): 1357-1392.
  • Pacher P, Bátkai S, Kunos G. The Endocannabinoid system as an emerging goal of pharmacotherapy. pharmacol rev . 2006 September; 58 (3): 389–462.
  • Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D. Cannabidiol improves the anandamide signaling and relieves the psychotic symptoms of schizophrenia. translate psychiatry. 2012 Mär 20; 2: E94.
  • Professor Gene Bruno, MS, MHS, The provost for Huntington College for Health Sciences, is a nutritionist, herbalist, author and educator. For more than 37 years, he has trained and trained natural product retailers and medical staff, researched and formulated natural products for dozens of food supplements and formulated articles on nutrition, herbal medicine, nutrotquional agents and integrative health issues for trade and consumers. It can be reached at gbruno@hchs.edu.

    • 2-AG
    • aea
    • cbd
    • CBD/Phytocannabinoid
    • ecs
    • endocannabinoid system
    • faah
    • fatty acid hydrolase
    • n-arachidonyllethanolamide
    • Phytocannabinoid
    • Prof. Gene Bruno Blog
    • SN-2-Arachidonoylglycerol
    • Testosterone

    Read original items in English.